Fibroblast growth factors: Key players in epithelial morphogenesis, repair and cytoprotection

Current Opinion in Biotechnology

Volumn 14, Issue 5, 2003, Pages 533-537

  Steiling, Heike ^a,b   Werner, Sabine ^a  

^a ETH ZURICH   (Switzerland)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 4; KERATINOCYTE GROWTH FACTOR; REACTIVE OXYGEN METABOLITE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DAMAGE; CELL PROTECTION; CLINICAL TRIAL; HUMAN; MORPHOGENESIS; MUCOSA INFLAMMATION; NEUROPROTECTION; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE DIFFERENTIATION; TISSUE REPAIR; ULCER; WOUND HEALING;

EID: 0142090636     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2003.08.003     Document Type: Review

References (49)

1. Ornitz DM, Itoh N: Fibroblast growth factors. Genome Biol 2001, 2: reviews 3005.
2. Johnson D.E., Williams L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1993;1-41.
3. Basilico C., Moscatelli D. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:1992;115-165.
4. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9:1998;153-165.
5. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer. 7:2000;165-197.
6. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Phys. Rev. 83:2003;835-870.
7. Abraham JA, Klagsbrun M: Modulation of wound repair by members of the fibroblast growth factor family. In The Molecular and Cellular Biology of Wound Repair, edn 2. Edited by RAF Clark: Plenum Press: New York; 1996:195-248.
8. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA. 95:1998;5672-5677.
9. Miller D.L., Ortega S., Bashayan O., Basch R., Basilico C. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell. Biol. 20:2000;2260-2268.
10. Alzheimer C., Werner S. Fibroblast growth factors and neuroprotection. Adv. Exp. Med. Biol. 513:2002;335-351.
11. Yoshimura S., Takagi Y., Harada J., Teramoto T., Thomas S.S., Waeber C., Bakowska J.C., Breakefield X.O., Moskowitz M.A. FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc. Natl. Acad. Sci. USA. 98:2001;5874-5879.
12. Floss T., Arnold H.H., Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11:1997;2040-2051.
13. Igarashi M., Finch P.W., Aaronson S.A. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J. Biol. Chem. 273:1998;13230-13235.
14. Nakatake Y., Hoshikawa M., Asaki T., Kassai Y., Itoh N. Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle. Biochim. Biophys. Acta. 1517:2001;460-463.
15. Arman E., Haffner-Krausz R., Chen Y., Heath J.K., Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA. 95:1998;5082-5087.
16. De Moerlooze L., Spencer-Dene B., Revest J., Hajihosseini M., Rosewell I., Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development. 127:2000;483-492 This paper describes the phenotype of FGFR2-IIIb knockout mice. Agenesis and dysgenesis of several organs were observed, demonstrating that FGFR2-IIIb is crucial for epithelial morphogenesis.
17. Revest J.M., Spencer-Dene B., Kerr K., De Moerlooze L., Rosewell I., Dickson C. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1 or Bmp4. Dev. Biol. 231:2001;47-62.
18. Revest J.M., Suniara R.K., Kerr K., Owen J.J., Dickson C. Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J. Immunol. 167:2001;1954-1961.
19. Mailleux A.A., Spencer-Dene B., Dillon C., Ndiaye D., Savona-Baron C., Itoh N., Kato S., Dickson C., Thiery J.P., Bellusci S. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development. 129:2002;53-60.
20. Pulkkinen M.A., Spencer-Dene B., Dickson C., Otonkoski T. The IIIb isoform of fibroblast growth factor receptor 2 is required for proper growth and branching of pancreatic ductal epithelium but not for differentiation of exocrine or endocrine cells. Mech. Dev. 120:2003;167-175.
21. Min H., Danilenko D.M., Scully S.A., Bolon B., Ring B.D., Tarpley J.E., DeRose M., Simonet W.S. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12:1998;3156-3161.
22. Sekine K., Ohuchi H., Fujiwara M., Yamasaki M., Yoshizawa T., Sato T., Yagishita N., Matsui D., Koga Y., Itoh N.et al. Fgf10 is essential for limb and lung formation. Nat. Genet. 21:1999;138-141.
23. Ohuchi H., Hori Y., Yamasaki M., Harada H., Sekine K., Kato S., Itoh N. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 277:2000;643-649.
24. Pirvola U., Spencer-Dene B., Xing-Qun L., Kettunen P., Thesleff I., Fritzsch B., Dickson C., Ylikoski J. FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis. J. Neurosci. 20:2000;6125-6134.
25. Guo L., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10:1996;165-175.
26. Qiao J., Uzzo R., Obara-Ishihara T., Degenstein L., Fuchs E., Herzlinger D. FGF-7 modulates ureteric bud growth and nephron number in the developing kidney. Development. 126:1999;547-554.
27. Mansour S.L., Goddard J.M., Capecchi M.R. Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development. 117:1993;13-28.
28. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA. 89:1992;6896-6900.
29. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., Hofschneider P.H., Williams L.T. The function of KGF in morphogenesis of epithelium and re-epithelialization of wounds. Science. 266:1994;819-822.
30. Beer H.D., Florence C., Dammeier J., McGuire L., Werner S., Duan D.R. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene. 15:1997;2211-2218.
31. Jameson J., Ugarte K., Chen N., Yachi P., Fuchs E., Boismenu R., Havran W.L. A role for skin γδ T cells in wound repair. Science. 296:2002;747-749 Wound healing studies in mice lacking γδ TCR-bearing dendritic epidermal T cells revealed a crucial role of these cells in re-epithelialization, most likely due to their production of FGF-7 and FGF-10.
32. Boismenu R., Havran W.L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science. 266:1994;1253-1255.
33. Beyer T.A., Werner S., Dickson C., Grose R. Fibroblast growth factor 22 and its potential role during skin development and repair. Exp. Cell. Res. 287:2003;228-236.
34. Finch P.W., Pricolo V., Wu A., Finkelstein S.D. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology. 110:1996;441-451.
35. Brauchle M., Madlener M., Wagner A.D., Angermeyer K., Lauer U., Hofschneider P.H., Gregor M., Werner S. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149:1996;521-529.
36. Chen Y., Chou K., Fuchs E., Havran W.L., Boismenu R. Protection of the intestinal mucosa by intra-epithelial γδ T cells. Proc. Natl. Acad. Sci. USA. 99:2002;14338-14343 Using a dextran sulfate sodium induced mouse model of colitis, the authors demonstrate increased mucosal injury and delayed tissue repair in FGF-7-deficient mice. Delayed repair was also reported in mice lacking FGF-7 producing γδ TCR-bearing dendritic epidermal T cells.
37. Steiling H., Wüstefeld T., Bugnon P., Brauchle M., Fässler R., Teupser D., Thiery J., Gordon J.I., Trautwein C., Werner S. Fibroblast growth factor receptor signalling is crucial for liver homeostasis and repair. Oncogene. 22:2003;4380-4388 By expression of a dominant-negative FGF receptor mutant in hepatocytes of transgenic mice, a crucial role of FGF receptor signalling in hepatocyte proliferation after partial hepatectomy was observed. This is the first in vivo evidence for a function of FGFs in liver repair.
38. Hu Z., Evarts R.P., Fujio K., Marsden E.R., Thorgeirsson S.S. Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat. Cell. Growth Differ. 6:1995;1019-1025.
39. Yu C., Wang F., Kan M., Jin C., Jones R.B., Weinstein M., Deng C.X., McKeehan W.L. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275:2000;15482-15489.
40. Yu C., Wang F., Jin C., Wu X., Chan W.K., McKeehan W.L. Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am. J. Pathol. 161:2002;2003-2010.
41. Jimenez P.A., Rampy M.A. Keratinocyte growth factor-2 accelerates wound healing in incisional wounds. J. Surg. Res. 81:1999;238-242.
42. Robson M.C., Phillips T.J., Falanga V., Odenheimer D.J., Parish L.C., Jensen J.L., Steed D.L. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 9:2001;347-352 This clinical study describes a beneficial effect of FGF-10 for the treatment of human venous ulcers.
43. Min D., Taylor P.A., Panoskaltsis-Mortari A., Chung B., Danilenko D.M., Farrell C., Lacey D.L., Blazar B.R., Weinberg K.I. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 99:2002;4592-4600 In a murine bone marrow transplantation model, thymic injury and prolonged immune deficiency were prevented by pre-treatment with FGF-7.
44. Rossi S., Blazar B.R., Farrell C.L., Danilenko D.M., Lacey D.L., Weinberg K.I., Krenger W., Hollander G.A. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood. 100:2002;682-691 After bone marrow transplantation in mice, FGF-7 averted graft-versus-host disease-related injury of thymic epithelial cells.
45. Farrell C.L., Rex K.L., Chen J.N., Bready J.V., DiPalma C.R., Kaufman S.A., Rattan A., Scully S., Lacey D.L. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif. 35(Suppl 1):2002;78-85 Using a mouse model of intestinal epithelial injury, the authors demonstrate a potent cytoprotective effect of FGF-7 for intestinal epithelial cells in vivo, suggesting the use of FGF-7 for the treatment of mucositis in cancer patients.
46. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X., Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. USA. 100:2003;6098-6103 By inducible expression of FGF-7 and a dominant-negative Akt mutant in the lung of transgenic mice, the authors show that FGF-7 can protect lung epithelial cells from hyperoxia via activation of the antiapoptotic Akt signalling axis.
47. Frank S., Munz B., Werner S. The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene. 14:1997;915-921.
48. Munz B., Frank S., Hubner G., Olsen E., Werner S. A novel type of glutathione peroxidase: expression and regulation during wound repair. Biochem. J. 326:1997;579-585.
49. Braun S., Hanselmann C., Gassmann M.G., auf dem Keller U., Born-Berclaz C., Chan K., Kan Y.W., Werner S. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22:2002;5492-5505 The identification of the Nrf2 transcription factor as a target of FGF-7 in keratinocytes suggests a crucial role for Nrf2 in the cytoprotective effect of FGF-7. A function of this transcription factor in wound healing is demonstrated.